D.E. Shaw & Co
MBOT icon

D.E. Shaw & Co’s Microbot Medical MBOT Stock Holding History

D.E. Shaw & Co’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-783
Closed -$69K – 3474
2017
Q1 		$69K Buy
+783
New +$68.8K ﹤0.01% 3211
2016
Q4 		– Sell
-1,969
Closed -$362K – 3531
2016
Q3 		$362K Buy
+1,969
New +$257K ﹤0.01% 2964
2016
Q2 		– Sell
-16
Closed -$7K – 3448
2016
Q1 		$7K Sell
16
-34
-68% -$18K ﹤0.01% 3361
2015
Q4 		$34K Buy
50
+24
+92% +$17.6K ﹤0.01% 3734
2015
Q3 		$18K Buy
26
+8
+44% +$6.08K ﹤0.01% 3683
2015
Q2 		$16K Buy
18
+8
+80% +$9.41K ﹤0.01% 3708
2015
Q1 		$17K Sell
10
-44
-81% -$78.6K ﹤0.01% 3571
2014
Q4 		$82K Buy
54
+43
+391% +$78.1K ﹤0.01% 3919
2014
Q3 		$23K Sell
11
-7
-39% -$18.5K ﹤0.01% 4038
2014
Q2 		$59K Buy
18
+5
+38% +$11.5K ﹤0.01% 4104
2014
Q1 		$29K Sell
13
-12
-48% -$28.7K ﹤0.01% 4214
2013
Q4 		$51K Sell
25
-10
-29% -$21.2K ﹤0.01% 4395
2013
Q3 		$94K Buy
35
+3
+9% +$8.14K ﹤0.01% 4195
2013
Q2 		$85K Buy
+32
New +$90.2K ﹤0.01% 3887

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

D.E. Shaw & Co's MBOT Position: Q2 2017 in Review

D.E. Shaw & Co sold out of Microbot Medical (MBOT) in Q2 2017, closing a stake of 783 shares — an estimated $69K sold.

D.E. Shaw & Co first reported a position in MBOT in Q2 2013 and held it in 14 quarters. The position peaked at $362K in Q3 2016. 24 funds tracked by Wall St. Rank hold MBOT as of Q2 2017.

  • D.E. Shaw & Co reported no remaining Microbot Medical position as of Q2 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 783 Microbot Medical shares in Q2 2017, an estimated $69K.
  • D.E. Shaw & Co first reported a position in Microbot Medical in Q2 2013 and held it in 14 quarters.
  • D.E. Shaw & Co's Microbot Medical position peaked at $362K in Q3 2016.
  • 24 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.